Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2026Archives of cardiovascular diseases

Determinants of appropriate therapies in patients with hypertrophic cardiomyopathy implanted with an ICD. Results from a remote monitoring cohort

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJ. BurbotLDLaura DelsarteLPLeslie Placide

Discussion

Loading...

Member takes

Overview

Observational cohort identifies therapy determinants in hypertrophic cardiomyopathy patients with ICD, suggesting implications for treatment strategies.

Key Points

  • To identify factors influencing the choice of therapies for hypertrophic cardiomyopathy patients with an implanted ICD.
  • Utilized a remote monitoring cohort of patients with hypertrophic cardiomyopathy.
  • Analyzed data relating to therapy appropriateness and patient outcomes.
  • Assessed the impact of various clinical factors on therapy selection.
  • Certain clinical characteristics significantly influence therapy decisions for patients.
  • Remote monitoring provides valuable insights into patient management over time.
  • The study identifies actionable insights that could enhance treatment strategies.

Cite This Study

Burbot et al. (2026) studied this question.

synapsesocial.com/papers/696135a4766f0a95ea6adc86https://doi.org/10.1016/j.acvd.2025.10.191
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identifying the vulnerable: navigating the predictors of implantable cardioverter defibrillator (ICD) therapy in the moderately reduced ejection fraction (EF) cohort2026 · 1 citations
  2. 2Implantable Cardioverter–Defibrillator Therapies Following Generator Replacements—Long-Term Remote Monitoring Data2025 · 1 citations
  3. 3Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators2025
  4. 4Predictors of recurrent ventricular arrhythmias and the impact of genetic testing in a hypertrophic cardiomyopathy patient cohort at long term follow up2026
  5. 5Dutch outcome in implantable cardioverter-defibrillator therapy extended follow up do it xl long term outcomes in a large primary prevention population2026